Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-019774
Filing Date
2017-10-23
Accepted
2017-10-23 16:31:20
Documents
40
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnov-10q_20170930.htm 10-Q 699880
2 EX-31.1 mnov-ex311_7.htm EX-31.1 11008
3 EX-31.2 mnov-ex312_9.htm EX-31.2 10913
4 EX-32.1 mnov-ex321_6.htm EX-32.1 7881
5 EX-32.2 mnov-ex322_10.htm EX-32.2 7812
  Complete submission text file 0001564590-17-019774.txt   2316539

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mnov-20170930.xml EX-101.INS 324063
7 XBRL TAXONOMY EXTENSION SCHEMA mnov-20170930.xsd EX-101.SCH 22340
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnov-20170930_cal.xml EX-101.CAL 23519
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnov-20170930_def.xml EX-101.DEF 69529
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20170930_lab.xml EX-101.LAB 196264
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20170930_pre.xml EX-101.PRE 143842
Mailing Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

EIN.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33185 | Film No.: 171149233
SIC: 2834 Pharmaceutical Preparations